A5076950806- Blood Coagulation and Thrombosis Mechanisms
- Antifungal resistance and susceptibility
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Hemophilia Treatment and Research
- Asthma and respiratory diseases
- Fungal Infections and Studies
- Parasitic Diseases Research and Treatment
- Diabetes and associated disorders
- Platelet Disorders and Treatments
- Blood disorders and treatments
- Antimicrobial Resistance in Staphylococcus
- Pharmacovigilance and Adverse Drug Reactions
- Mechanical Circulatory Support Devices
- Myasthenia Gravis and Thymoma
- Chronic Disease Management Strategies
- Breastfeeding Practices and Influences
- Dermatological and Skeletal Disorders
- Antibiotics Pharmacokinetics and Efficacy
- Neonatal Respiratory Health Research
- Respiratory and Cough-Related Research
Hospital Universitario Nuestra Señora de Candelaria
2023-2024
Introducción: La enfermedad de Von Willebrand (EvW), el trastorno hemorrágico congénito más frecuente, precisa una atención coordinada entre primaria y la unidad coagulopatías referencia para garantizar un diagnóstico adecuado manejo farmacoterapéutico seguro en estos pacientes. Objetivo: estudiar concordancia los registros (AP) especializada (AE), subsanar las discrepancias encontradas. Método: Estudio dos fases. Fase 1: estudio retrospectivo diagnósticos tratamientos AP pacientes con EvW...
<h3>Background and Importance</h3> Vancomycin is used in the treatment of resistant gram-positive microorganism infections. Due to a narrow therapeutic range, its use limited by nephrotoxicity, which ranges from 5–43% according literature. Therefore, it's important identify patients who may benefit pharmacokinetic monitoring. The duration high minimum concentration vancomycin are factors associated with nephrotoxicity. <h3>Aim Objectives</h3> To determine incidence nephrotoxicity monitored...